This patience applies equally to people transitioning from compounded tirzepatide or any other GLP-1 medication
Retatrutide is being studied in ongoing clinical trials, including programs evaluating obesity, overweight with weight-related conditions, type 2 diabetes, obstructive sleep apnea, osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Further Increases: Depending on the efficacy and tolerability, the dose can be increased to 10 mg once weekly after at least 4 weeks on the 5 mg dose, and potentially to 15 mg once weekly after at least another 4 weeks
Effects of iron overload on mitochondrial functions Although mitochondria are the major consumers of iron, excess iron in the mitochondrial matrix can result in the generation of ROS and subsequent oxidative damage to the mitochondrial membrane